Cancer Biology & Medicine

►►Submit your paper by clicking the ABOVE RED TAG "ONLINE SUBMISSION".

 

►►Very important notification on publication fee

Effective February 2019, Cancer Biology & Medicine, as an open access journal, will charge a reasonable publication fee of $1,500/¥10,000 for each accepted article (all article types). No fees will be charged for invited articles.


Cancer Biology & Medicine

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the China Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine

Author Benefits

● Easy submission via online system

● Efficient and professional peer review

● Rapid pre-print online publication

● No charge for publication and open access

● International visibility-All full texts are free in PubMed Central

 

Announcements

 

Publication of the 1st issue in 2020

 

The first two editorials are both related to precision oncology. One indicates the topic on Human Pan-genome Analysis system (HUPAN), and another focuses on CRISPR-Cas13a system.

As for the reviews and original articles, many of them presents that some molecules acting as biomarkers or therapeutic targets affect or regulate tumorigenesis or development of cancer, such as ABC transporters, N6-methyladenosine, COX-2, CDK11, 27-hydroxycholesterol-induced EndMT, and so on. Besides, articles on clinical research also show some state-of-the-art viewpoints in diagnosis and treatment for gastric cancer, esophageal cancer, nasopharyngeal carcinoma, ovarian cancer, and other common cancers.

Last but not least, pursuing and reporting the latest results of studies on highlighted topics can be as an important mission for our journal. In this issue, readers could also find out novel information on cancer precision medicine, cancer immunotherapy, and so on. In a word, we hope the content of this issue will greatly benefit your research and clinical practice. Thank you for your attention and welcome to submit your work to Cancer Biology & Medicine.

 
Posted: 2020-02-14
 

The 21st SIS World Congress on Breast Cancer and Breast Healthcare

 

The 21st SIS World Congress on Breast Cancer and Breast Healthcare will be held on September 10 – 12 , 2020 in Athens, Greece.

Click here to learn more: https://www.sisbreast.org/


 
Posted: 2020-02-07
 
More Announcements...

Vol 17, No 1: February 2020

Table of Contents



OUR FRIENDS